Artelo Biosciences Inc (NAS:ARTL)
$ 1.1152 -0.004 (-0.36%) Market Cap: 3.60 Mil Enterprise Value: -1.88 Mil PE Ratio: 0 PB Ratio: 0.49 GF Score: 37/100

Artelo Biosciences Inc at Benzinga All Access Event (Virtual) Transcript

Jul 11, 2023 / 03:00PM GMT
Release Date Price: $2.04 (+0.26%)
Unidentified Participant

And welcome in Greg, CEO and President of Artelo Biosciences. Thank you for joining us. How are you?

Gregory Gorgas
Artelo Biosciences, Inc. - President & CEO

Great to be here. Thank you very much, Michael.

Questions & Answers

Unidentified Participant

It's a pleasure to have you. Thank you for taking time out of what I'm sure is a busy Tuesday for you. We're coming in here off the holiday season. We had July 4 last week, a lot of traders out of the office. Quiet in the markets. Quiet on the news front, but we're back in action here with the new week. So Greg, kick us off, give us a brief introduction to Artelo Biosciences and what you guys do with the company.

Gregory Gorgas
Artelo Biosciences, Inc. - President & CEO

Thank you very much. Well, we're a biopharmaceutical company and we're headquartered here in San Diego. We were founded in 2017. And it was on the promise that lipid-signaling or modulating the endocannabinoid system could have a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot